Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pulmonology

Living with PVOD and Long-Term Monitoring

At a Glance

Living with pulmonary venoocclusive disease (PVOD) requires specialized pulmonary hypertension monitoring, carefully paced activity, prescribed oxygen, and early transplant planning. Avoid strenuous exertion and discuss travel, pregnancy, and worsening symptoms with your care team.

Living with Pulmonary Venoocclusive Disease (PVOD) requires a shift in how you approach your daily life and your medical care. Because the disease can progress more quickly than other forms of pulmonary hypertension, your long-term management focuses on three pillars: meticulous monitoring by experts, protecting your heart through paced activity, and optimizing your oxygen levels [1][2].

The Importance of Specialized Monitoring

Because PVOD is exceptionally rare, it cannot be managed effectively by a general doctor alone. Your care should be led by a Specialized Pulmonary Hypertension Center that works closely with a lung transplant team, and coordinated with your primary care physician, cardiologist, and palliative or supportive care clinicians [3][4].

Your team will use several tools to track your status. While there is no universal “calendar” for testing, common surveillance includes:

  • Six-Minute Walk Test (6MWT): This is one of the important markers for your prognosis. Doctors track how far you can walk and how much your oxygen levels drop during the test [1][5].
  • Echocardiograms: Regular ultrasounds of the heart allow your team to monitor right ventricular remodeling, which is how the right side of your heart changes as it works against high lung pressure [6].
  • DLCO and Lung Function: Periodic testing of your diffusing capacity (how well oxygen enters your blood) helps track the health of your lung’s small vessels [5][7].
  • Risk Assessment: Your doctors will use a combination of these assessments, including symptoms, hemodynamics, and oxygenation, to determine your overall trajectory and inform transplant decisions [1].

Pacing and Physical Activity

In many conditions, “pushing yourself” is seen as a positive. In PVOD, however, unsupervised overexertion can put dangerous stress on your heart. Activity should be focused on pacing rather than performance.

  • Listen to Your Body: Use short, slow bouts of activity rather than long sessions. Rest before you become severely breathless [1]. Give yourself clear stop symptoms.
  • Avoid Strenuous Exertion: Unsupervised activities that involve heavy lifting, straining (like the Valsalva maneuver), or high-intensity cardio should be avoided unless specifically cleared by your PH specialist [8].
  • Pulmonary Rehabilitation: Stable patients may benefit from a supervised exercise program, but this must be individualized. A specialist will titrate your oxygen and monitor your heart rate during exercise to ensure it is safe [8].
  • Altitude and Travel: High altitudes have less oxygen, which can be dangerous for PVOD patients. Always discuss air travel or trips to mountain regions with your doctor first, as you may need increased oxygen during flights [9].

Living with Supplemental Oxygen

Many people with PVOD will require supplemental oxygen to treat documented low blood oxygen (hypoxemia) [10]. Because your lungs struggle to transfer oxygen into your blood, providing a higher concentration of oxygen can reduce the strain on your heart and help ease breathlessness [11].

  • Ambulatory Oxygen: You will likely need oxygen specifically during activity. Your team should perform a “titration” test to find the exact flow rate (liters per minute) you need while walking versus resting [10][5]. Do not change your oxygen flow rate based on a home reading alone without consulting your prescribing team.
  • Safety First: Oxygen is a fire hazard. Never smoke while using oxygen, and stay at least five feet away from open flames, such as gas stoves or candles.
  • Consistency: Even if you feel “okay,” use your oxygen exactly as prescribed. It is a medication designed to protect your body from the long-term effects of low oxygen (hypoxemia) [9].

Reproductive Health

Pulmonary hypertension and PVOD make pregnancy exceptionally high-risk, carrying a severe risk of maternal death, and many medications used for transplant or PH care can cause severe fetal harm. Preconception counseling, discussions about highly effective individualized contraception, and avoiding pregnancy are critical components of care. If you become pregnant, contact your PH or transplant team immediately.

Mental Health and Support

Living with a rare, life-threatening disease like PVOD is emotionally taxing. The uncertainty of the transplant timeline and the limitations on your physical activity can lead to anxiety, depression, or a sense of isolation [12].

  • Seek Specialized Support: Look for a therapist or support group familiar with chronic lung disease or organ transplantation. Palliative care clinicians can also provide excellent symptom and emotional support.
  • Caregiver Support: Ensure your family or caregivers have their own support system, as the demands of managing PVOD and the transplant process can lead to significant caregiver strain.
  • Advance Care Planning: While it can be difficult, having honest conversations with your team and family about your wishes for care provides peace of mind and ensures your voice is heard throughout your journey [12].

While the path with PVOD is challenging, being proactive with your monitoring and protective of your energy allows you to maintain the best possible quality of life. For information on when daily symptoms become medical emergencies, please refer to the Symptoms and Warning Signs page.

Common questions in this guide

How is pulmonary venoocclusive disease monitored over time?
There is no single testing schedule for PVOD. A specialized pulmonary hypertension team may use six-minute walk tests, echocardiograms, DLCO and other lung-function tests, symptoms, blood-flow and pressure measurements, and oxygen levels to track changes. The results can help guide decisions about transplant evaluation.
What kind of activity is safe with PVOD?
Most people should pace activity with short, easy bouts and rest before severe breathlessness. Avoid heavy lifting, straining, and high-intensity exercise unless your pulmonary hypertension specialist approves them. If you are stable, supervised pulmonary rehabilitation may help, with oxygen and heart rate monitored.
How should I use oxygen with PVOD?
Use supplemental oxygen at the flow rate prescribed after testing during rest and activity. Do not change the rate based only on a home reading; ask your prescribing team first. Keep oxygen away from smoking, open flames, and other fire hazards.
Can I travel or fly with PVOD?
Air travel and high-altitude trips can lower the oxygen available to your body and may worsen symptoms. Talk with your pulmonary hypertension team before flying or visiting mountain regions, because you may need more oxygen during travel.
Is pregnancy safe with PVOD?
Pregnancy is exceptionally high risk in PVOD and pulmonary hypertension, and some medicines used for this care can seriously harm a fetus. Discuss pregnancy avoidance, individualized contraception, and preconception counseling with your care team. If you become pregnant, contact your pulmonary hypertension or transplant team immediately.
What emotional support can help me live with PVOD?
A therapist or support group familiar with chronic lung disease or transplantation can help with anxiety, depression, isolation, and lifestyle changes. Palliative care clinicians can also provide symptom and emotional support, and caregivers should seek support for themselves as well.

Get notified when new evidence is published on Pulmonary venoocclusive disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Outcomes and risk assessment in pulmonary veno-occlusive disease.

    Boucly A, Solinas S, Beurnier A, et al.

    ERJ open research 2024; (10(1)) doi:10.1183/23120541.00612-2023.

    PMID: 38226059
  2. 2

    Pulmonary veno-occlusive disease: A systematic review of risk factors, clinical presentation, diagnostic investigations, treatment outcomes and prognostic factors.

    Thong LP, Hakak-Zargar B, Burns AT, et al.

    Journal of medical imaging and radiation oncology 2025; (69(2)):186-197 doi:10.1111/1754-9485.13814.

    PMID: 39661909
  3. 3

    Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task.

    Cazeiro DI, Plácido R, Raposo MA, et al.

    Arquivos brasileiros de cardiologia 2024; (121(4)):e20230565 doi:10.36660/abc.20230565.

    PMID: 38695472
  4. 4

    Pulmonary veno-occlusive disease: a paradigm of diagnosis and therapeutic challenges in pulmonary hypertension.

    Aguado B, Grynblat J, Budhram B, et al.

    Current opinion in pulmonary medicine 2025; (31(5)):443-455 doi:10.1097/MCP.0000000000001184.

    PMID: 40471666
  5. 5

    Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.

    Ogawa A, Takahashi Y, Matsubara H

    Journal of cardiology 2018; (72(3)):255-260 doi:10.1016/j.jjcc.2018.02.009.

    PMID: 29548663
  6. 6

    Revisiting REVEAL-ECHO: A Focus on Pulmonary Veno-Occlusive Disease.

    Gutiérrez-Ortiz E, Jiménez López-Guarch C, Cruz-Utrilla A, et al.

    Archivos de bronconeumologia 2026; doi:10.1016/j.arbres.2026.05.002.

    PMID: 42173789
  7. 7

    Identification of pulmonary arterial hypertension patients with venous or capillary involvement.

    Andruska AM, Cruz-Utrilla A, Nossent EJ, et al.

    American journal of respiratory and critical care medicine 2026; (212(9)):2199-2210 doi:10.1093/ajrccm/aamag289.

    PMID: 42275164
  8. 8

    The role of cardiopulmonary exercise testing in identifying and monitoring pulmonary veno-oclusive disease: a case report with ING.

    Segura de la Cal T, Pérez-Olivares C, Cristo Ropero MJ, et al.

    European heart journal. Case reports 2022; (6(5)):ytac138 doi:10.1093/ehjcr/ytac138.

    PMID: 35592750
  9. 9

    Pulmonary veno-occlusive disease.

    Montani D, Lau EM, Dorfmüller P, et al.

    The European respiratory journal 2016; (47(5)):1518-34 doi:10.1183/13993003.00026-2016.

    PMID: 27009171
  10. 10

    Pulmonary Veno-occlusive Disease in a Military Pilot: Case Report and Mini-review.

    Radchenko G, Botsiuk Y, Dyadyk O, et al.

    Current cardiology reviews 2026; (22(5)):e1573403X412872 doi:10.2174/011573403X412872251107111309.

    PMID: 41588905
  11. 11

    Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.

    Hamada T, Takahashi H, Nakagawa M, et al.

    Case reports in oncology 2023; (16(1)):338-346 doi:10.1159/000530265.

    PMID: 37384208
  12. 12

    Pulmonary hypertension secondary to pulmonary veno-occlusive disease complicated by right heart failure, hypotension and acute kidney injury.

    Golzy N, Fernandes S, Sharim J, et al.

    Respiratory medicine case reports 2017; (20()):10-13 doi:10.1016/j.rmcr.2016.09.005.

    PMID: 27872804

This page provides informational education about living with PVOD and does not constitute medical advice. Follow your pulmonary hypertension or transplant team's individualized instructions for oxygen, activity, monitoring, pregnancy planning, and urgent concerns.